Your session is about to expire
← Back to Search
Neuromodulation for Heart Failure (TREAT-HF Trial)
TREAT-HF Trial Summary
This trial will study the effects of low-level tragus nerve stimulation on inflammatory cytokines in patients with acute decompensated heart failure.
TREAT-HF Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTREAT-HF Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.TREAT-HF Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have had surgery to cut the nerves to my stomach.I have Hepatitis C or HIV.You have a specific type of heart block called 2nd or 3rd degree AV block.I have been diagnosed with sick sinus syndrome.I have had a heart attack recently.I was admitted to the hospital for acute decompensated heart failure.My kidney function is severely reduced.I do not agree to participate in the study.You have a specific type of heart block or a very slow heart rhythm.I have had multiple fainting spells due to sudden drops in heart rate and blood pressure.I have a complex heart condition from birth.
- Group 1: Tragus Stimulation
- Group 2: Control group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Do the requirements of this trial extend to individuals younger than thirty-five?
"This research requires participants to be within the age range of 18-75. For those under 18, there are 22 trials available and for seniors over 65 years old, 693 studies can be found."
Would you be able to provide information on whether this experiment is currently enrolling participants?
"The public record of clinicaltrials.gov shows that this study is actively seeking participants, beginning on September 1st 2016 and most recently updated on December 16th 2021."
How many individuals are enrolled in this experimental research?
"Indeed, the information provided on clinicaltrials.gov shows that this research is actively enrolling participants. This study was originally proposed on September 1st 2016 and has since been updated as recently as December 16th 2021. 80 patients will be welcomed at a single site to partake in this trial."
Are the requirements needed to join this medical examination within my reach?
"To take part in this medical trial, applicants must have a diagnosis of heart failure and be between 18-75 years old. 80 people are being invited to join the study."
Share this study with friends
Copy Link
Messenger